SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 133, Issue 20, Pages 2085-2105
Publisher
Portland Press Ltd.
Online
2019-10-11
DOI
10.1042/cs20190666
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth
- (2019) Liangliang Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- FBXO22 possesses both pro-tumorigenic and anti-metastatic roles in breast cancer progression
- (2018) Rui Sun et al. CANCER RESEARCH
- The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis
- (2018) Junyi Shen et al. DIGESTIVE DISEASES AND SCIENCES
- SETD3 negatively regulates VEGF expression during hypoxic pulmonary hypertension in rats
- (2018) Xiufeng Jiang et al. HYPERTENSION RESEARCH
- DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer
- (2018) Weiying Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SETD3 is an actin histidine methyltransferase that prevents primary dystocia
- (2018) Alex W. Wilkinson et al. NATURE
- SETD3 protein is the actin-specific histidine N-methyltransferase
- (2018) Sebastian Kwiatkowski et al. eLife
- Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis
- (2017) Xiaoqing Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3
- (2017) Lai Wei et al. JOURNAL OF HEPATOLOGY
- Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma
- (2017) Xiao Fei et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Correlations between TBL1XR1 and recurrence of colorectal cancer
- (2017) Hongda Liu et al. Scientific Reports
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
- (2016) Ying Zhu et al. HUMAN PATHOLOGY
- Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27
- (2016) Dong Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Chromatin associated SETD3 negatively regulates VEGF expression
- (2016) Ofir Cohn et al. Scientific Reports
- Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
- (2015) T. Powrózek et al. Clinical & Translational Oncology
- Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication
- (2015) Ana Sílvia Pires-Luís et al. Epigenetics
- Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis
- (2015) Chun-Ming Wong et al. HEPATOLOGY
- The recently suggested intestinal cancer stem cell markerDCLK1is an epigenetic biomarker for colorectal cancer
- (2014) Hege Marie Vedeld et al. Epigenetics
- Effect of the downregulation of SMYD3 expression by RNAi on RIZ1 expression and proliferation of esophageal squamous cell carcinoma
- (2014) SHANG-WEN DONG et al. ONCOLOGY REPORTS
- The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis
- (2013) Z. Chen et al. HAEMATOLOGICA
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
- (2012) Kim Andresen et al. Epigenetics
- Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
- (2012) Sandy Leung-Kuen Au et al. HEPATOLOGY
- Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b
- (2012) Dorothy Ngo-Yin Fan et al. HEPATOLOGY
- Characterization of a Novel Histone H3K36 Methyltransferase setd3 in Zebrafish
- (2011) Dong-Wook KIM et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- DCAMKL-1 Regulates Epithelial-Mesenchymal Transition in Human Pancreatic Cells through a miR-200a-Dependent Mechanism
- (2011) S. M. Sureban et al. CANCER RESEARCH
- Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
- (2011) Qian Zhou et al. Future Oncology
- Histone Methyltransferase SETD3 Regulates Muscle Differentiation
- (2011) Gwang Hyeon Eom et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Dnmt3a PWWP Domain Reads Histone 3 Lysine 36 Trimethylation and Guides DNA Methylation
- (2010) Arunkumar Dhayalan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function
- (2009) Peng Wang et al. CARCINOGENESIS
- Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B
- (2009) Sheng-Han Wang et al. HEPATOLOGY
- Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3β kinase pathways
- (2009) Wan-Jen Yang et al. HEPATOLOGY
- Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
- (2008) Timothy A Yap et al. CURRENT OPINION IN PHARMACOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started